As of 2025-03-19, the Relative Valuation of Collegium Pharmaceutical Inc (COLL) is 49.26 USD. This relative valuation is based on P/E multiples. With the latest stock price at 29.82 USD, the upside of Collegium Pharmaceutical Inc based on Relative Valuation is 65.2%.
The range of the Relative Valuation is 45.88 - 55.66 USD.
| Range | Selected | |
| Trailing P/E multiples | 20.9x - 24.7x | 22.4x |
| Forward P/E multiples | 18.7x - 21.3x | 18.9x |
| Fair Price | 45.88 - 55.66 | 49.26 |
| Upside | 53.8% - 86.7% | 65.2% |
| Date | P/E |
| 2025-03-18 | 13.49 |
| 2025-03-17 | 13.50 |
| 2025-03-14 | 13.41 |
| 2025-03-13 | 13.24 |
| 2025-03-12 | 13.49 |
| 2025-03-11 | 13.65 |
| 2025-03-10 | 13.50 |
| 2025-03-07 | 13.16 |
| 2025-03-06 | 13.56 |
| 2025-03-05 | 12.96 |
| 2025-03-04 | 12.76 |
| 2025-03-03 | 12.94 |
| 2025-02-28 | 13.22 |
| 2025-02-27 | 12.93 |
| 2025-02-26 | 12.90 |
| 2025-02-25 | 13.12 |
| 2025-02-24 | 13.29 |
| 2025-02-21 | 13.26 |
| 2025-02-20 | 13.54 |
| 2025-02-19 | 13.61 |
| 2025-02-18 | 13.52 |
| 2025-02-14 | 13.50 |
| 2025-02-13 | 14.10 |
| 2025-02-12 | 13.89 |
| 2025-02-11 | 14.37 |
| 2025-02-10 | 13.89 |
| 2025-02-07 | 14.03 |
| 2025-02-06 | 14.09 |
| 2025-02-05 | 13.98 |
| 2025-02-04 | 14.08 |
| 2025-02-03 | 14.20 |
| 2025-01-31 | 14.62 |
| 2025-01-30 | 14.80 |
| 2025-01-29 | 14.76 |
| 2025-01-28 | 14.91 |
| 2025-01-27 | 15.43 |
| 2025-01-24 | 14.83 |
| 2025-01-23 | 14.49 |
| 2025-01-22 | 14.81 |
| 2025-01-21 | 15.11 |
| 2025-01-17 | 15.18 |
| 2025-01-16 | 15.23 |
| 2025-01-15 | 15.00 |
| 2025-01-14 | 15.10 |
| 2025-01-13 | 15.38 |
| 2025-01-10 | 14.98 |
| 2025-01-08 | 15.17 |
| 2025-01-07 | 13.26 |
| 2025-01-06 | 13.03 |
| 2025-01-03 | 13.43 |